Vexim SA
Industry
- Biotechnology
- Medical Devices
- Biomaterials
- Surgical Equipment & Devices
- Minimally or Less Invasive
- Implantable Devices
Other Names/Subsidiaries
- Vexim, Inc.
Latest on Vexim SA
Truffle Capital has raised €250m ($278m) million for a new medtech dedicated fund. The French VC firm said its BioMedTech fund will be used to launch 12 medtech companies, based on disruptive technolo
Device Transactions Device fundraising in Q4 2017 totaled $2.6 billion, the highest single-quarter value of the year. However, total 2017 financing for the industry declined from 2016: $8.4 billion in
Medtech mergers and acquisitions went full pelt in October, with 30 deals announced and closed in the month, the highest level of activity so far this year. The surge of M&A activity trounced the 10 d
IN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over